Vimarsana
Biggest News Aggregation in the World

Page 3 - William Bonello News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from William Bonello. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In William Bonello Today - Breaking & Trending Today

-$0.19 Earnings Per Share Expected for NeoGenomics, Inc. (NASDAQ:NEO) This Quarter - Vimarsana News

-$0.19 Earnings Per Share Expected for NeoGenomics, Inc. (NASDAQ:NEO) This Quarter

Equities analysts expect NeoGenomics, Inc. (NASDAQ:NEO – Get Rating) to post earnings per share (EPS) of ($0.19) for the current quarter, according to Zacks. Four analysts have provided estimates for NeoGenomics’ earnings, with estimates ranging from ($0.27) to ($0.10). NeoGenomics reported earnings per share of ($0.04) in the same quarter last year, which suggests a […]

3,700 Shares in NeoGenomics, Inc. (NASDAQ:NEO) Bought by National Bank of Canada FI - Vimarsana News

3,700 Shares in NeoGenomics, Inc. (NASDAQ:NEO) Bought by National Bank of Canada FI

National Bank of Canada FI acquired a new position in shares of NeoGenomics, Inc. (NASDAQ:NEO – Get Rating) during the 4th quarter, Holdings Channel.com reports. The firm acquired 3,700 shares of the medical research company’s stock, valued at approximately $126,000. A number of other institutional investors have also modified their holdings of NEO. Thrivent Financial […]

NeoGenomics, Inc. (NASDAQ:NEO) Receives $25.36 Consensus Target Price from Brokerages - Vimarsana News

NeoGenomics, Inc. (NASDAQ:NEO) Receives $25.36 Consensus Target Price from Brokerages

Shares of NeoGenomics, Inc. (NASDAQ:NEO – Get Rating) have received an average recommendation of “Hold” from the thirteen brokerages that are covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, four have given a hold rating and six have given a buy rating to the company. The average […]

Benchmark Cuts NeoGenomics (NASDAQ:NEO) Price Target to $16.00 - Vimarsana News

Benchmark Cuts NeoGenomics (NASDAQ:NEO) Price Target to $16.00

NeoGenomics (NASDAQ:NEO – Get Rating) had its price objective cut by Benchmark from $26.00 to $16.00 in a research report sent to investors on Tuesday, The Fly reports. A number of other research firms have also recently issued reports on NEO. SVB Leerink cut their price objective on NeoGenomics from $45.00 to $20.00 and set […]

Needham & Company LLC Trims NeoGenomics (NASDAQ:NEO) Target Price to $19.00 - Vimarsana News

Needham & Company LLC Trims NeoGenomics (NASDAQ:NEO) Target Price to $19.00

NeoGenomics (NASDAQ:NEO – Get Rating) had its price objective trimmed by Needham & Company LLC from $29.00 to $19.00 in a report issued on Tuesday, The Fly reports. The firm currently has a buy rating on the medical research company’s stock. Other research analysts also recently issued research reports about the company. SVB Leerink reduced […]